Explore evidence

13.3 per_100_person_yearsIn patients with pre-ART CD4 cell count <200 cells/μL, incidence of severe morbidity was 13.3 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations

37.9 %Overall, 36 (37.9%) HIV-2 patients presented with advanced HIV disease at their last visit.

Côte d'IvoireVIH avancé · VIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

4 %Among hospitalized HIV-positive adults in West Africa who died, the underlying cause of death was non-specific illness or unknown cause in 4% of cases.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

10 %Atypical haplotypes were detected in 10% of the samples.

Côte d'Ivoirehemoglobin disordersHAL · Unilimdocument of 23 observations

5 %The prevalence of HIV drug resistance mutations (HIVDRM) is scored as low (≤ 5%) in all five study sites — Thailand, Vietnam, Burkina Faso, Côte d'Ivoire, and Senegal — for the three drug classes analyzed.

Burkina Faso · Côte d'Ivoire · SénégalVIH/sidapublished 2009AIDS Research and Human RetrovirusesOpenAlexdocument of 3 observations

25 %Pulmonary embolism (PE) was found in 9 out of 36 HIV-infected patients, representing 25%.

Côte d'Ivoirepulmonary embolism · VIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

154 /μLMean CD4 count at antiretroviral therapy initiation was 154/μL.

Côte d'IvoireVIH/sidapublished 2016Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 5 observations

33 %Tuberculosis was present in 33% of the HIV-infected patients.

Côte d'Ivoiretuberculose · VIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

98.9 %Among 93 patients tested, 92 (98.9%) harbored HBV genotype E.

Côte d'Ivoirehépatite Bpublished 2016Journal of gastroenterology and hepatologyeurope_pmcdocument of 11 observationsDOI 10.1111/jgh.13156

472 per_mm3The median CD4+ cell count among 791 HIV-infected patients was 472/mm³.

Côte d'IvoireVIH/sidaobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations

86 deathsAmong 2056 HIV-infected adults in Côte d'Ivoire, 86 deaths were recorded over 9404 patient-years of follow-up.

Côte d'IvoireVIH/sidapublished 2017The Lancet. Global healtheurope_pmcdocument of 6 observations

61.7 %Gastrointestinal adverse effects were reported by 79 patients (61.7%).

Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations

41 %All three patients had heterozygous haemoglobin AS sickle cell disease with haemoglobin S percentages of 41%, 45%, and 50%.

Côte d'Ivoirehaemoglobin AS sickle cell diseasepublished 2009Antiviral therapyeurope_pmcdocument of 11 observations

Infection prevalence remained uniformly high between 91.8% and 95.0%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

5.8 %Of 551 HIV-2 patients on ART, 5.8% died during the median time on ART of 2.4 years.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

99.5 %QFT-GIT negative predictive value for active TB was 99.5%.

Côte d'Ivoiretuberculosepublished 2014PloS oneeurope_pmcdocument of 8 observations

68.4 %Among the 95 HIV-2 patients enrolled in the 'success cohort', 65 (68.4%) remained in care.

Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

8.5 %Among 791 HIV-infected patients in West Africa, 67 (8.5%) were HBsAg positive.

Côte d'Ivoirehépatite B · VIH/sidaobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations

151 patientsAntiretroviral prophylaxis was prescribed to 151 AEB patients.

Côte d'IvoireVIH/sidaobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

27.7 %The prevalence of malaria cases detected by RDTs among children aged 5–8 years was 27.7%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

0.63 hazard_ratio6 months of isoniazid preventive therapy reduced all-cause mortality with a hazard ratio of 0.63 (95% CI 0.41 to 0.97) in HIV-infected adults in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2017The Lancet. Global healtheurope_pmcdocument of 6 observations

3.7 %HCV prevalence was 3.7% among HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

16 %The West and Central African region registers 16% of new HIV infections worldwide.

Côte d'IvoireVIH/sidapublished 2020International journal of infectious diseases : IJID : official publication of the Internateurope_pmcdocument of 3 observations

7.8 %Of 422 HIV-2-infected patients, 33 (7.8%) were treated with three NRTIs.

Côte d'IvoireVIH/sidapublished 2016Journal of the International AIDS Societyeurope_pmcdocument of 6 observations

20 %Less than one-fifth of AGLHIV received at least one dose of HPV vaccine in Côte d'Ivoire in 2025.

Côte d'Ivoireinfection à HPVobserved 2025HAL · Unilimdocument of 69 observations